346 related articles for article (PubMed ID: 11558827)
1. New and emerging therapies for pulmonary complications of cystic fibrosis.
Tonelli MR; Aitken ML
Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies in cystic fibrosis.
Anderson P
Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment of the ion transport defect in cystic fibrosis.
Roomans GM
Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
Ghigo A; Prono G; Riccardi E; De Rose V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
[TBL] [Abstract][Full Text] [Related]
5. Targeting airway inflammation in cystic fibrosis.
McElvaney OJ; Wade P; Murphy M; Reeves EP; McElvaney NG
Expert Rev Respir Med; 2019 Nov; 13(11):1041-1055. PubMed ID: 31530195
[No Abstract] [Full Text] [Related]
6. Emerging drugs for cystic fibrosis.
Amin R; Ratjen F
Expert Opin Emerg Drugs; 2014 Mar; 19(1):143-55. PubMed ID: 24479826
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
Perrem L; Ratjen F
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
Cantin AM; Hartl D; Konstan MW; Chmiel JF
J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
[TBL] [Abstract][Full Text] [Related]
9. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.
Amaral MD
J Intern Med; 2015 Feb; 277(2):155-166. PubMed ID: 25266997
[TBL] [Abstract][Full Text] [Related]
10. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
11. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for cystic fibrosis: what's in the pipeline?
Frerichs C; Smyth A
Expert Opin Pharmacother; 2009 May; 10(7):1191-202. PubMed ID: 19405793
[TBL] [Abstract][Full Text] [Related]
13. Emerging treatments in cystic fibrosis.
Jones AM; Helm JM
Drugs; 2009 Oct; 69(14):1903-10. PubMed ID: 19747007
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
[TBL] [Abstract][Full Text] [Related]
15. Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.
Torphy TJ; Allen J; Cantin AM; Konstan MW; Accurso FJ; Joseloff E; Ratjen FA; Chmiel JF;
Ann Am Thorac Soc; 2015 Sep; 12(9):1398-406. PubMed ID: 26146892
[TBL] [Abstract][Full Text] [Related]
16. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
[TBL] [Abstract][Full Text] [Related]
17. Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
Gillan JL; Davidson DJ; Gray RD
Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303535
[TBL] [Abstract][Full Text] [Related]
18. [Cystic fibrosis lung disease and its management].
Hidaka N; Hidaka Y
Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
[TBL] [Abstract][Full Text] [Related]
19. [Patients with cystic fibrosis become adults : Treatment hopes and disappointments].
Eschenhagen P; Schwarz C
Internist (Berl); 2019 Jan; 60(1):98-108. PubMed ID: 30627755
[TBL] [Abstract][Full Text] [Related]
20. Advances in cystic fibrosis therapies.
Rowe SM; Clancy JP
Curr Opin Pediatr; 2006 Dec; 18(6):604-13. PubMed ID: 17099358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
